Treatment results of high-risk defined by NCI criteria childhood acute lymphoblastic leukemia in AIEOP-ALL studies over two decades.

被引：0
|
作者：
Aricò, M
Conter, V
Valsecchi, MG
Rizzari, C
Barisone, E
Messina, C
Lo Nigro, L
Pinta, MF
De Rossi, G
Pession, A
Testi, AM
Santoro, N
Di Tullio, MT
Micalizzi, C
Favre, C
Lippi, A
Rondelli, R
Silvestri, D
Biondi, A
Basso, G
Masera, G
机构：
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2001
引用
收藏
页码：464A / 465A
页数：2
相关论文
共 50 条
  • [41] Kinetics of minimal residual disease (MRD) in 47 patients with high-risk childhood acute lymphoblastic leukemia treated in the ongoing trial ALL-BFM 2000.
    Schrauder, A
    Flohr, T
    Koch, D
    Stanulla, M
    Bürger, B
    Welte, K
    Bartram, C
    Schrappe, M
    BLOOD, 2002, 100 (11) : 754A - 755A
  • [42] Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial
    Horibe, Keizo
    Yumura-Yagi, Keiko
    Kudoh, Tooru
    Nishimura, Shinichiro
    Oda, Megumi
    Yoshida, Makoto
    Komada, Yoshihiro
    Hara, Junichi
    Tawa, Akio
    Usami, Ikuya
    Tanizawa, Akihiko
    Kato, Koji
    Kobayashi, Ryoji
    Matsuo, Keitaro
    Hori, Hiroki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (02) : 81 - 89
  • [43] Three-drug induction and BFM-type intensive consolidation chemotherapy for treatment of standard risk childhood acute lymphoblastic leukemia defined also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) study ALL-9501.
    Arico, M
    Conter, V
    Valsecchi, MG
    Boccalatte, MFP
    Barisone, E
    Messina, C
    De Rossi, G
    Lo Nigro, L
    Pession, A
    Locatelli, F
    Micalizzi, C
    Basso, G
    Masera, G
    BLOOD, 2004, 104 (11) : 538A - 538A
  • [44] ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD - RESULTS OF A THERAPY PROTOCOL INCLUDING BONE-MARROW TRANSPLANTATION DURING THE 1ST REMISSION FOR HIGH-RISK PATIENTS
    MICHEL, G
    MARANINCHI, D
    THURET, I
    FAY, C
    GUITARD, AM
    MOZZICONACCI, MJ
    NOVAKOVITCH, G
    CAPODANO, AM
    TUBIANA, N
    PERRIMOND, H
    ARCHIVES FRANCAISES DE PEDIATRIE, 1990, 47 (03): : 163 - 168
  • [45] Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95
    Schrauder, Andre
    Reiter, Alfred
    Gadner, Helmut
    Niethammer, Dietrich
    Klingebiel, Thomas
    Kremens, Bernhard
    Peters, Christina
    Ebell, Wolfram
    Zimmermann, Martin
    Niggli, Felix
    Ludwig, Wolf-Dieter
    Riehm, Hansjoerg
    Welte, Karl
    Schrappe, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5742 - 5749
  • [46] Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial
    Ribera, Josep-Maria
    Oriol, Albert
    Morgades, Mireia
    Sarra, Josep
    Montesinos, Pau
    Brunet, Salut
    Guardia, Ramon
    Abellan, Pascual Fernandez
    Bernal, Teresa
    Bermudez, Arancha
    Moreno, Maria-Jose
    Parody, Ricardo
    Tormo, Mar
    Del Potro, Eloy
    Llorente, Andreu
    Garcia-Boyero, Raimundo
    Esteve, Jordi
    Rabunal, Maria-Jose
    Pardal, Emilia
    Grande, Carlos
    Bueno, Javier
    Cladera, Antonia
    Bethencourt, Concepcion
    Martin-Reina, Victoria
    Amigo, Maria-Luz
    Hernandez-Rivas, Jesus-Maria
    Sanz, Miguel-Angel
    Feliu, Evarist
    BLOOD, 2008, 112 (11) : 1130 - 1130
  • [47] CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations:: results of the German Multicenter Trials for Adult ALL (GMALL)
    Gleissner, B
    Goekbuget, N
    Rieder, H
    Arnold, R
    Schwartz, S
    Diedrich, H
    Schoch, C
    Heinze, B
    Fonatsch, C
    Bartram, CR
    Hoelzer, D
    Thiel, E
    BLOOD, 2005, 106 (13) : 4054 - 4056
  • [48] Pharmacoanalytical assays of Erwinia asparaginase (Erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients:: Simulations of Erwinase population PK-PD models
    Avramis, Vassilios I.
    Martin-Aragon, Sagrario
    Avramis, Earl V.
    Asselin, Barbara L.
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2561 - 2572
  • [49] FISH-BASED SCREENING FOR TYROSINE KINASE-ACTIVATING FUSION GENES IN CHILDHOOD HIGH-RISK B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL)
    Nebral, K.
    Koenig, M.
    Attarbaschi, A.
    Mann, G.
    Haas, O. A.
    Strehl, S.
    HAEMATOLOGICA, 2015, 100 : 338 - 338
  • [50] Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
    Ribera, Josep-Maria
    Oriol, Albert
    Bethencourt, Concepcion
    Parody, Ricardo
    Hernandez-Rivas, Jesus-Maria
    Moreno, Maria-Jose
    del Potro, Eloy
    Tormo, Mar
    Rivas, Concepcion
    Besalduch, Joan
    Sanz, Miguel-Angel
    Ortega, Juan-Jose
    Feliu, E.
    Queipo de Llano, M. J.
    Fernandez-Abellan, P.
    Terol, M. J.
    Besalduch, J.
    Novo, A.
    Moscardo, F.
    Arias, J.
    Moraleda, J. M.
    Heras, I
    Bueno, J.
    Fernandez-Calvo, J.
    Borrego, D.
    Martin-Reina, V
    Deben, G.
    Carbonell, F.
    Orts, M.
    Vivancos, P.
    Grande, C.
    Bello, Jl
    Queizan, J. A.
    Guinea, J.
    Brunet, S.
    Bergua, J. L.
    Rodriguez-Villa, A.
    Atutxa, K.
    Diaz-Morfa, G.
    Hernandez-Nieto, L.
    Gamez, F.
    Llorente, A.
    Ortega-Rivas, F.
    Penarrubia, M. D.
    Poderos, C.
    Marti, J. M.
    Gardella, S.
    HAEMATOLOGICA, 2005, 90 (10) : 1346 - 1356
12345